Cargando…
Effects of tocilizumab and dexamethasone on the downregulation of proinflammatory cytokines and upregulation of antioxidants in the lungs in oleic acid-induced ARDS
BACKGROUND: Acute respiratory distress syndrome (ARDS) is a life-threatening disease caused by the induction of inflammatory cytokines and chemokines in the lungs. There is a dearth of drug applications that can be used to prevent cytokine storms in ARDS treatment. This study was designed to investi...
Autores principales: | Terzi, Funda, Demirci, Beste, Çınar, İrfan, Alhilal, Mohammad, Erol, Huseyin Serkan |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9482261/ https://www.ncbi.nlm.nih.gov/pubmed/36115998 http://dx.doi.org/10.1186/s12931-022-02172-w |
Ejemplares similares
-
Dexamethasone/methylprednisolone/tocilizumab: Candidaemia: case report
Publicado: (2021) -
L. Cucurbita pepo modulates contact dermatitis in depressed rats through downregulation of proinflammatory cytokines and upregulation of antioxidant status
por: Ayuob, Nasra, et al.
Publicado: (2021) -
Therapeutic effects of minocycline on oleic acid-induced acute respiratory distress syndrome (ARDS) in rats
por: Ghasemzadeh Rahbardar, Mahboobeh, et al.
Publicado: (2023) -
Efficacy of tocilizumab in patients with COVID-19 ARDS undergoing noninvasive ventilation
por: Menzella, Francesco, et al.
Publicado: (2020) -
Dexamethasone/remdesivir/tocilizumab: Various toxicities: case report
Publicado: (2022)